MGMT and glioblastoma: The primary human glioblastoma lines NULU and ZAR, selected based on the methylation profile (unmethylated MGMT) and therefore resistant to treatment with alkylating drugs, were exposed to a combination of AE 20 μM and TMZ 10 μM for 24, 48, and 72 h.